City of Hope Opens National Lung Cancer Clinical Trial Seeking to Predict Immunotherapy Success
AI Briefing
- City of Hope opens Phase 2 clinical trial to study tumor resistance to immunotherapy.
- Trial aims to predict immunotherapy success by mapping tumor changes.
- Non-small cell lung cancer patients eligible for the trial in Pennsylvania.
Context
City of Hope has opened a Phase 2 clinical trial to study how tumors change when they start to resist immunotherapy. The trial aims to map these changes in order to better understand the treatment.
The trial's research will focus on advanced non-small cell lung cancer, seeking to predict the success of immunotherapy in treating the disease.
Advertisement